BACKGROUND: Several studies have addressed the epidemiology of community-associated Staphylococcus aureus (CA-SA) in Europe; nonetheless, a comprehensive perspective remains unclear. In this study, we aimed to describe the population structure of CA-SA and to shed light on the origin of methicillin-resistant S. aureus (MRSA) in this continent. METHODS AND FINDINGS: A total of 568 colonization and infection isolates, comprising both MRSA and methicillin-susceptible S. aureus (MSSA), were recovered in 16 European countries, from community and community-onset infections. The genetic background of isolates was characterized by molecular typing techniques (spa typing, pulsed-field gel electrophoresis and multilocus sequence typing) and the presence of PVL and ACME was tested by PCR. MRSA were further characterized by SCCmec typing. We found that 59% of all isolates were associated with community-associated clones. Most MRSA were related with USA300 (ST8-IVa and variants) (40%), followed by the European clone (ST80-IVc and derivatives) (28%) and the Taiwan clone (ST59-IVa and related clonal types) (15%). A total of 83% of MRSA carried Panton-Valentine leukocidin (PVL) and 14% carried the arginine catabolic mobile element (ACME). Surprisingly, we found a high genetic diversity among MRSA clonal types (ST-SCCmec), Simpson's index of diversity = 0.852 (0.788-0.916). Specifically, about half of the isolates carried novel associations between genetic background and SCCmec. Analysis by BURP showed that some CA-MSSA and CA-MRSA isolates were highly related, suggesting a probable local acquisition/loss of SCCmec. CONCLUSIONS: Our results imply that CA-MRSA origin, epidemiology and population structure in Europe is very dissimilar from that of USA.

Department of Medical Microbiology 2nd Faculty of Medicine Charles University Prague Czech Republic

Department of Medical Microbiology University Medical Center Utrecht Utrecht The Netherlands

Laboratory of Microbiology The Rockefeller University New York New York United States of America

Laboratory of Molecular Genetics Instituto de Tecnologia Quimica e Biologica Universidade Nova de Lisboa Oeiras Portugal

Laboratory of Molecular Genetics Instituto de Tecnologia Química e Biológica Universidade Nova de Lisboa Oeiras Portugal

Laboratory of the National Bone Marrow Transplantation Centre Bab Saadoun Tunis Tunisia

National Medicines Institute Division of Clinical Microbiology and Infection Prevention Warsaw Poland

National Reference Laboratory for Antibiotics National Institute of Public Health Prague Czech Republic

000      

00000naa a2200000 a 4500

001      

bmc14071215

003      

CZ-PrNML

005      

20190509131235.0

007      

ta

008      

140915s2012 xxu f 000 0|eng||

009      

AR

024    7_

$a 10.1371/journal.pone.0034768 $2 doi

035    __

$a (PubMed)22558099

040    __

$a ABA008 $d ABA008 $e AACR2 $b cze

041    0_

$a eng

044    __

$a xxu

100    1_

$a Rolo, Joana $u Laboratory of Molecular Genetics, Instituto de Tecnologia Quimica e Biologica, Universidade Nova de Lisboa, Oeiras, Portugal

245    10

$a High genetic diversity among community-associated Staphylococcus aureus in Europe: results from a multicenter study / $c Joana Rolo, Maria Miragaia, Agata Turlej-Rogacka, Joanna Empel, Ons Bouchami, Nuno A. Faria, Ana Tavares, Waleria Hryniewicz, Ad C. Fluit, Hermínia de Lencastre and the CONCORD Working Group, Oto Melter, Helena Žemličková, Marta Fridrichová

520    9_

$a BACKGROUND: Several studies have addressed the epidemiology of community-associated Staphylococcus aureus (CA-SA) in Europe; nonetheless, a comprehensive perspective remains unclear. In this study, we aimed to describe the population structure of CA-SA and to shed light on the origin of methicillin-resistant S. aureus (MRSA) in this continent. METHODS AND FINDINGS: A total of 568 colonization and infection isolates, comprising both MRSA and methicillin-susceptible S. aureus (MSSA), were recovered in 16 European countries, from community and community-onset infections. The genetic background of isolates was characterized by molecular typing techniques (spa typing, pulsed-field gel electrophoresis and multilocus sequence typing) and the presence of PVL and ACME was tested by PCR. MRSA were further characterized by SCCmec typing. We found that 59% of all isolates were associated with community-associated clones. Most MRSA were related with USA300 (ST8-IVa and variants) (40%), followed by the European clone (ST80-IVc and derivatives) (28%) and the Taiwan clone (ST59-IVa and related clonal types) (15%). A total of 83% of MRSA carried Panton-Valentine leukocidin (PVL) and 14% carried the arginine catabolic mobile element (ACME). Surprisingly, we found a high genetic diversity among MRSA clonal types (ST-SCCmec), Simpson's index of diversity = 0.852 (0.788-0.916). Specifically, about half of the isolates carried novel associations between genetic background and SCCmec. Analysis by BURP showed that some CA-MSSA and CA-MRSA isolates were highly related, suggesting a probable local acquisition/loss of SCCmec. CONCLUSIONS: Our results imply that CA-MRSA origin, epidemiology and population structure in Europe is very dissimilar from that of USA.

590    __

$a bohemika - dle Pubmed

650    02

$a techniky typizace bakterií $x metody $7 D015373

650    12

$a infekce získané v komunitě $x epidemiologie $x mikrobiologie $7 D017714

650    02

$a pulzní gelová elektroforéza $7 D016521

650    02

$a ženské pohlaví $7 D005260

650    12

$a genetická variace $7 D014644

650    02

$a populační genetika $7 D005828

650    02

$a lidé $7 D006801

650    02

$a mužské pohlaví $7 D008297

650    12

$a methicilin rezistentní Staphylococcus aureus $x genetika $7 D055624

650    02

$a mikrobiální testy citlivosti $7 D008826

650    02

$a polymerázová řetězová reakce $7 D016133

650    12

$a stafylokokové infekce $x epidemiologie $x mikrobiologie $7 D013203

650    12

$a Staphylococcus aureus $x genetika $7 D013211

651    _2

$a Evropa $x epidemiologie $7 D005060

655    _2

$a multicentrická studie $7 D016448

655    _2

$a práce podpořená grantem $7 D013485

700    1_

$a Miragaia, Maria $u Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal

700    1_

$a Turlej-Rogacka, Agata $u National Medicines Institute, Division of Clinical Microbiology and Infection Prevention, Warsaw, Poland

700    1_

$a Empel, Joanna $u National Medicines Institute, Division of Clinical Microbiology and Infection Prevention, Warsaw, Poland

700    1_

$a Bouchami, Ons $u Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal; Laboratory of the National Bone Marrow Transplantation Centre, Bab Saadoun, Tunis, Tunisia

700    1_

$a Faria, Nuno A. $u Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal

700    1_

$a Tavares, Ana $u Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal

700    1_

$a Hryniewicz, Waleria $u National Medicines Institute, Division of Clinical Microbiology and Infection Prevention, Warsaw, Poland

700    1_

$a Fluit, Ad C. $u Department of Medical Microbiology, University Medical Center Utrecht, Utrecht, The Netherlands

700    1_

$a de Lencastre, Hermínia $u Laboratory of Molecular Genetics, Instituto de Tecnologia Química e Biológica, Universidade Nova de Lisboa, Oeiras, Portugal; Laboratory of Microbiology, The Rockefeller University, New York, New York, United States of America

700    1_

$a Melter, Oto, $7 xx0102242 $u Department of Medical Microbiology, 2nd Faculty of Medicine, Charles University, Prague, Czech Republic $d 1965-

700    1_

$a Žemličková, Helena, $7 xx0092228 $u National Reference Laboratory for Antibiotics, National Institute of Public Health, Prague, Czech Republic $d 1970-

700    1_

$a Fridrichová, Marta $7 xx0159351 $u National Reference Laboratory for Antibiotics, National Institute of Public Health, Prague, Czech Republic

773    0_

$t PloS one $x 1932-6203 $g Roč. 7, č. 4 (2012), s. e34768 $w MED00180950

910    __

$a ABA008 $y 4 $z 0

990    __

$a 20140915143956 $b ABA008

991    __

$a 20190509131332 $b ABA008

999    __

$a ok $b bmc $g 1038963 $s 870081

BAS    __

$a 3

BMC    __

$a 2012 $b 7 $c 4 $d e34768 $i 1932-6203 $m PLoS One $n PLoS One $x MED00180950

GRA    __

$a NS9642 $p MZ0

GRA    __

$a NT12395 $p MZ0

LZP    __

$a 2014-09/abbo